Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children
Public ClinicalTrials.gov record NCT04987762. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multicenter, Multiple-Dose, Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children 4 to 12 Years of Age
Study identification
- NCT ID
- NCT04987762
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Purdue Pharma LP
- Industry
- Enrollment
- 103 participants
Conditions and interventions
Conditions
Interventions
- Adhansia XR Drug
Drug
Eligibility (public fields only)
- Age range
- 4 Years to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2, 2021
- Primary completion
- Apr 26, 2022
- Completion
- Apr 26, 2022
- Last update posted
- Aug 21, 2023
2021 – 2022
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Preferred Research Partners, Inc. | Little Rock | Arkansas | 72211 | — |
| MCB Clinical Research Centers, LLC | Colorado Springs | Colorado | 80910 | — |
| Clinical Neuroscience Solutions, Inc. | Jacksonville | Florida | 32256 | — |
| Adaptive Clinical Research, Inc. | Lauderhill | Florida | 33319 | — |
| Accel Research Sites - Maitland Clinical Research Unit | Maitland | Florida | 32751 | — |
| Clinical Neuroscience Solutions, Inc. | Orlando | Florida | 32801 | — |
| iResearch Atlanta, LLC | Decatur | Georgia | 30030 | — |
| Sisu BHR, LLC | Springfield | Massachusetts | 01103 | — |
| Clinical Research of Southern Nevada, LLC | Las Vegas | Nevada | 89128 | — |
| IPS Research Company | Oklahoma City | Oklahoma | 73106 | — |
| Clinical Neuroscience Solutions, Inc. | Memphis | Tennessee | 38119 | — |
| Red Oak Psychiatry Associates, PA | Houston | Texas | 77090 | — |
| Family Psychiatry of the Woodlands | The Woodlands | Texas | 77381 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98007 | — |
| Eastside Therapeutic Resource, Inc. dba Core Clinical Research | Everett | Washington | 98201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04987762, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 21, 2023 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04987762 live on ClinicalTrials.gov.